Omeros faces EU setback as CHMP reiterates negative opinion for narsoplimab in TA-TMA
Market Chameleon (Fri, 16-Oct 7:05 AM)
Surging YARTEMLEA Revenues and Bold Debt Reduction Mark Omeros’ Transformative Quarter
Market Chameleon (Thu, 13-Aug 10:32 AM)
Market Chameleon (Mon, 3-Aug 8:40 AM)
